Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study
2024

Using Smartphones to Measure Motor and Cognitive Functions in Multiple Sclerosis

Sample size: 153 publication 10 minutes Evidence: moderate

Author Information

Author(s): Mavragani Amaryllis, Erel Suat, Billis Antonis, Scaramozza Matthew, Ruet Aurélie, Chiesa Patrizia A, Ahamada Laïtissia, Bartholomé Emmanuel, Carment Loïc, Charre-Morin Julie, Cosne Gautier, Diouf Léa, Guo Christine C, Juraver Adrien, Kanzler Christoph M, Karatsidis Angelos, Mazzà Claudia, Penalver-Andres Joaquin, Ruiz Marta, Saubusse Aurore, Simoneau Gabrielle, Scotland Alf, Sun Zhaonan, Tang Minao, van Beek Johan, Zajac Lauren, Belachew Shibeshih, Brochet Bruno, Campbell Nolan

Primary Institution: Biogen

Hypothesis

Can a framework for selecting sensor-derived measures (SDMs) improve the assessment of cognitive and motor functions in people with multiple sclerosis (MS) using smartphones?

Conclusion

Smartphone-based assessments can reliably provide high-quality measures of cognitive and motor function in people with MS.

Supporting Evidence

  • 16 out of 47 sensor-derived measures (SDMs) passed the selection framework.
  • Selected SDMs showed moderate-to-good reliability with intraclass correlation coefficients ranging from 0.5 to 0.85.
  • Smartphone-based cognitive tests demonstrated good-to-excellent correlation with in-clinic assessments.

Takeaway

This study shows that smartphones can help doctors check how well people with multiple sclerosis are doing by measuring their thinking and movement skills.

Methodology

The study involved a cross-sectional analysis of data from 85 people with MS and 68 healthy participants who completed smartphone-based assessments.

Potential Biases

Potential biases in self-reported data and adherence to test instructions.

Limitations

The study had a relatively small sample size and focused on participants with mild disability.

Participant Demographics

Participants included 85 people with MS aged 18-64 and 68 matched healthy participants.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2196/60673

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication